First EU launches for J&J's Doribax
This article was originally published in Scrip
Executive Summary
Janssen-Cilag(Johnson & Johnson) has begun the EU roll out of its broad-spectrum carbapenem antibiotic Doribax (doripenem, 500mg powder for solution), following its recent EU approval for a range of hospital-based infections.